Beigene Stock Net Income
| 49BA Stock | EUR 296.00 6.00 2.07% |
As of the 6th of February, BeiGene shows the Mean Deviation of 1.84, risk adjusted performance of 0.0595, and Downside Deviation of 2.07. BeiGene technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BeiGene mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation to decide if BeiGene is priced correctly, providing market reflects its regular price of 296.0 per share.
BeiGene Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization 32.8 B | Enterprise Value Revenue 7.5263 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -580.3 M | -609.3 M | |
| Net Loss | -1.8 B | -1.7 B | |
| Net Loss | -580.3 M | -609.3 M |
BeiGene | Net Income |
The Net Income trend for BeiGene offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether BeiGene is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest BeiGene's Net Income Growth Pattern
Below is the plot of the Net Income of BeiGene over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in BeiGene financial statement analysis. It represents the amount of money remaining after all of BeiGene operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is BeiGene's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in BeiGene's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (644.79 M) | 10 Years Trend |
|
Net Income |
| Timeline |
BeiGene Net Income Regression Statistics
| Arithmetic Mean | (604,718,834) | |
| Coefficient Of Variation | (98.78) | |
| Mean Deviation | 462,886,836 | |
| Median | (580,307,400) | |
| Standard Deviation | 597,364,846 | |
| Sample Variance | 356844.8T | |
| Range | 1.9B | |
| R-Value | (0.61) | |
| Mean Square Error | 239917T | |
| R-Squared | 0.37 | |
| Significance | 0.01 | |
| Slope | (71,926,598) | |
| Total Sum of Squares | 5709516.1T |
BeiGene Net Income History
BeiGene 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BeiGene's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BeiGene.
| 11/08/2025 |
| 02/06/2026 |
If you would invest 0.00 in BeiGene on November 8, 2025 and sell it all today you would earn a total of 0.00 from holding BeiGene or generate 0.0% return on investment in BeiGene over 90 days. BeiGene is related to or competes with X-FAB Silicon, Advanced Medical, Nicola Mining, DXC Technology, SMA Solar, Sunny Optical, and Beta Systems. BeiGene, Ltd., a commercial-stage biotechnology company, develops and commercializes molecularly-targeted and immuno-onc... More
BeiGene Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BeiGene's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BeiGene upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.07 | |||
| Information Ratio | 0.0511 | |||
| Maximum Drawdown | 13.59 | |||
| Value At Risk | (2.90) | |||
| Potential Upside | 4.41 |
BeiGene Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BeiGene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BeiGene's standard deviation. In reality, there are many statistical measures that can use BeiGene historical prices to predict the future BeiGene's volatility.| Risk Adjusted Performance | 0.0595 | |||
| Jensen Alpha | 0.1573 | |||
| Total Risk Alpha | 0.0458 | |||
| Sortino Ratio | 0.0588 | |||
| Treynor Ratio | (12.35) |
BeiGene February 6, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0595 | |||
| Market Risk Adjusted Performance | (12.34) | |||
| Mean Deviation | 1.84 | |||
| Semi Deviation | 1.79 | |||
| Downside Deviation | 2.07 | |||
| Coefficient Of Variation | 1427.11 | |||
| Standard Deviation | 2.38 | |||
| Variance | 5.67 | |||
| Information Ratio | 0.0511 | |||
| Jensen Alpha | 0.1573 | |||
| Total Risk Alpha | 0.0458 | |||
| Sortino Ratio | 0.0588 | |||
| Treynor Ratio | (12.35) | |||
| Maximum Drawdown | 13.59 | |||
| Value At Risk | (2.90) | |||
| Potential Upside | 4.41 | |||
| Downside Variance | 4.29 | |||
| Semi Variance | 3.19 | |||
| Expected Short fall | (2.33) | |||
| Skewness | 0.9734 | |||
| Kurtosis | 2.03 |
BeiGene Backtested Returns
At this point, BeiGene is very steady. BeiGene secures Sharpe Ratio (or Efficiency) of 0.0414, which signifies that the company had a 0.0414 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for BeiGene, which you can use to evaluate the volatility of the firm. Please confirm BeiGene's Mean Deviation of 1.84, risk adjusted performance of 0.0595, and Downside Deviation of 2.07 to double-check if the risk estimate we provide is consistent with the expected return of 0.0965%. BeiGene has a performance score of 3 on a scale of 0 to 100. The firm shows a Beta (market volatility) of -0.0127, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning BeiGene are expected to decrease at a much lower rate. During the bear market, BeiGene is likely to outperform the market. BeiGene right now shows a risk of 2.33%. Please confirm BeiGene mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation , to decide if BeiGene will be following its price patterns.
Auto-correlation | -0.47 |
Modest reverse predictability
BeiGene has modest reverse predictability. Overlapping area represents the amount of predictability between BeiGene time series from 8th of November 2025 to 23rd of December 2025 and 23rd of December 2025 to 6th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BeiGene price movement. The serial correlation of -0.47 indicates that about 47.0% of current BeiGene price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.47 | |
| Spearman Rank Test | -0.58 | |
| Residual Average | 0.0 | |
| Price Variance | 111.71 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
BeiGene Net Interest Income
Net Interest Income |
|
Based on the recorded statements, BeiGene reported net income of (644.79 Million). This is 288.93% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all Germany stocks is significantly higher than that of the company.
BeiGene Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BeiGene's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of BeiGene could also be used in its relative valuation, which is a method of valuing BeiGene by comparing valuation metrics of similar companies.BeiGene is currently under evaluation in net income category among its peers.
BeiGene Fundamentals
| Return On Equity | 0.0181 | ||||
| Return On Asset | 0.0169 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 31.68 B | ||||
| Shares Outstanding | 101.81 M | ||||
| Shares Owned By Insiders | 17.30 % | ||||
| Shares Owned By Institutions | 31.29 % | ||||
| Price To Book | 9.18 X | ||||
| Price To Sales | 6.59 X | ||||
| Revenue | 3.81 B | ||||
| Gross Profit | 4.29 B | ||||
| EBITDA | 328.17 M | ||||
| Net Income | (644.79 M) | ||||
| Cash And Equivalents | 1.54 B | ||||
| Cash Per Share | 25.49 X | ||||
| Total Debt | 851.53 M | ||||
| Debt To Equity | 17.50 % | ||||
| Current Ratio | 6.46 X | ||||
| Book Value Per Share | 31.63 X | ||||
| Cash Flow From Operations | (140.63 M) | ||||
| Earnings Per Share | 0.44 X | ||||
| Target Price | 264.04 | ||||
| Number Of Employees | 11 K | ||||
| Beta | 0.52 | ||||
| Market Capitalization | 32.75 B | ||||
| Total Asset | 5.92 B | ||||
| Retained Earnings | (8.61 B) | ||||
| Working Capital | 1.78 B | ||||
| Net Asset | 5.92 B |
About BeiGene Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BeiGene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeiGene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeiGene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in BeiGene Stock please use our How to Invest in BeiGene guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.